St. Jude Augments AF Division With $47 Mil. Irvine Biomedical Purchase
This article was originally published in The Gray Sheet
Executive Summary
St. Jude will evaluate whether to pursue an atrial fibrillation indication for Irvine Biomedical, Inc.'s Therapy, Dual 8 and Cooled-Tip ablation catheters